Alteryx, Iovance Biotherapeutics And Other Big Stocks Moving Higher In Monday's Pre-Market Session

U.S. stock futures traded higher this morning on Monday. Here are some big stocks recording gains in today’s pre-market trading session.

  • Newegg Commerce, Inc. NEGG shares climbed 8.7% to $1.12 in pre-market trading after falling 5% on Friday.
  • Iovance Biotherapeutics, Inc. IOVA shares rose 7.2% to $5.65 in pre-market trading. Iovance Therapeutics shares jumped 13% on Friday after the company announced the FDA extended its BLA Priority Review for lifileucel amid resource constraints.
  • Bitfarms Ltd. BITF shares gained 6% to $1.24 in pre-market trading.
  • Nikola Corporation NKLA rose 5.9% to $1.26 in pre-market trading after gaining over 3% on Friday.
  • Alteryx, Inc. AYX shares gained 5.2% to $36.67 in pre-market trading. Morgan Stanley upgraded Alteryx from Equal-Weight to Overweight and announced a $54 price target.
  • TeraWulf Inc. WULF shares rose 4.7% to $1.76 in pre-market trading. TeraWulf recently announced Aug. 2023 production and operations updates.
  • Hyatt Hotels Corporation H shares climbed 4.7% to $112.54 in pre-market trading.
  • Kimbell Royalty Partners, LP KRP shares gained 4.6% to $16.25 in pre-market trading. Kimbell Royalty Partners recently closed $455 million acquisition of Permian and Mid-Con mineral and royalty interests in cash transaction.
  • Calliditas Therapeutics AB CALT shares gained 4.5% to $16.76 in pre-market trading. Calliditas Therapeutics is making significant strides in addressing rare kidney diseases. In a recent interview with Benzinga, the company’s CEO, Renee Aguiar-Lucander, provided valuable insights on various aspects of its work.

Now Read This: Investor Sentiment Declines After S&P 500 Falls For Second Straight Week

Don’t forget to check out our premarket coverage here

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!